CTLA4 and sarcoma: In addition, SMC4 is positively related to the expression of depleted T cell marker CTLA4, and CTLA4 is a key inhibitory immune checkpoint protein [22], which suggests that the high expression of SMC4 may inhibit the function of T cells and evade the immune response, thus promoting the development of sarcoma [23].